Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents. Materials and Methods:...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
| Series: | Indian Journal of Endocrinology and Metabolism |
| Subjects: | |
| Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=8;spage=458;epage=460;aulast=Atef |
| _version_ | 1818174709389328384 |
|---|---|
| author | Zayed Atef Abdulkareem Al-Khawlany Abdalla A Gunaid |
| author_facet | Zayed Atef Abdulkareem Al-Khawlany Abdalla A Gunaid |
| author_sort | Zayed Atef |
| collection | DOAJ |
| description | Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents. Materials and Methods: Data was collected at baseline, at 12 weeks and at 24 weeks. This short communication presents the results for patients enrolled from Yemen. Results: A total of 104 patients were enrolled in the study. Three different insulin analogue regimens were used in the study. Study patients had started on or were switched to biphasic insulin aspart (n = 94), insulin aspart (n = 4), basal insulin plus insulin aspart (n = 1) and other insulin combinations (n = 2). At baseline glycaemic control was poor for both insulin naïve (mean HbA1c: 10.6%) and insulin user (mean HbA1c: 9.8%) groups. After 24 weeks of treatment, both the study groups showed improvement in HbA1c (insulin naïve: −2.7%, insulin users: −1.8%). SADR′s including major hypoglycaemia events did not occur in any of the study patients. Conclusion: Starting or switching to insulin analogues was associated with improvement in glycaemic control with a low rate of hypoglycaemia. |
| first_indexed | 2024-12-11T19:48:43Z |
| format | Article |
| id | doaj.art-b52de0db502f4c29b6186fe456030caa |
| institution | Directory Open Access Journal |
| issn | 2230-8210 2230-9500 |
| language | English |
| last_indexed | 2024-12-11T19:48:43Z |
| publishDate | 2013-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Endocrinology and Metabolism |
| spelling | doaj.art-b52de0db502f4c29b6186fe456030caa2022-12-22T00:52:51ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002013-01-0117845846010.4103/2230-8210.122076Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve studyZayed AtefAbdulkareem Al-KhawlanyAbdalla A GunaidBackground: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents. Materials and Methods: Data was collected at baseline, at 12 weeks and at 24 weeks. This short communication presents the results for patients enrolled from Yemen. Results: A total of 104 patients were enrolled in the study. Three different insulin analogue regimens were used in the study. Study patients had started on or were switched to biphasic insulin aspart (n = 94), insulin aspart (n = 4), basal insulin plus insulin aspart (n = 1) and other insulin combinations (n = 2). At baseline glycaemic control was poor for both insulin naïve (mean HbA1c: 10.6%) and insulin user (mean HbA1c: 9.8%) groups. After 24 weeks of treatment, both the study groups showed improvement in HbA1c (insulin naïve: −2.7%, insulin users: −1.8%). SADR′s including major hypoglycaemia events did not occur in any of the study patients. Conclusion: Starting or switching to insulin analogues was associated with improvement in glycaemic control with a low rate of hypoglycaemia.http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=8;spage=458;epage=460;aulast=AtefA 1 chieve studyinsulin analoguestype 2 diabetes mellitusYemen |
| spellingShingle | Zayed Atef Abdulkareem Al-Khawlany Abdalla A Gunaid Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study Indian Journal of Endocrinology and Metabolism A 1 chieve study insulin analogues type 2 diabetes mellitus Yemen |
| title | Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study |
| title_full | Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study |
| title_fullStr | Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study |
| title_full_unstemmed | Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study |
| title_short | Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yemen cohort of the A 1 chieve study |
| title_sort | clinical experience with insulin detemir biphasic insulin aspart and insulin aspart in people with type 2 diabetes results from the yemen cohort of the a 1 chieve study |
| topic | A 1 chieve study insulin analogues type 2 diabetes mellitus Yemen |
| url | http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=8;spage=458;epage=460;aulast=Atef |
| work_keys_str_mv | AT zayedatef clinicalexperiencewithinsulindetemirbiphasicinsulinaspartandinsulinaspartinpeoplewithtype2diabetesresultsfromtheyemencohortofthea1chievestudy AT abdulkareemalkhawlany clinicalexperiencewithinsulindetemirbiphasicinsulinaspartandinsulinaspartinpeoplewithtype2diabetesresultsfromtheyemencohortofthea1chievestudy AT abdallaagunaid clinicalexperiencewithinsulindetemirbiphasicinsulinaspartandinsulinaspartinpeoplewithtype2diabetesresultsfromtheyemencohortofthea1chievestudy |